Ladenburg Thalmann Financial Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $7K | Sell |
113
-9
| -7% | -$558 | ﹤0.01% | 4661 |
|
|
2019
Q3 | $7K | Buy |
122
+80
| +190% | +$4.59K | ﹤0.01% | 4562 |
|
|
2019
Q2 | $2K | Hold |
42
| – | – | ﹤0.01% | 5019 |
|
|
2019
Q1 | $2K | Sell |
42
-33
| -44% | -$1.57K | ﹤0.01% | 4981 |
|
|
2018
Q4 | $3K | Sell |
75
-67
| -47% | -$2.68K | ﹤0.01% | 4813 |
|
|
2018
Q3 | $10K | Sell |
142
-3,257
| -96% | -$229K | ﹤0.01% | 4304 |
|
|
2018
Q2 | $178K | Hold |
3,399
| – | – | ﹤0.01% | 2325 |
|
|
2018
Q1 | $178K | Buy |
3,399
+50
| +1% | +$2.62K | ﹤0.01% | 2325 |
|
|
2017
Q4 | $179K | Hold |
3,349
| – | – | ﹤0.01% | 2285 |
|
|
2017
Q3 | $203K | Buy |
3,349
+31
| +0.9% | +$1.88K | ﹤0.01% | 2099 |
|
|
2017
Q2 | $261K | Buy |
3,318
+18
| +0.5% | +$1.42K | ﹤0.01% | 1825 |
|
|
2017
Q1 | $274K | Hold |
3,300
| – | – | ﹤0.01% | 1692 |
|
|
2016
Q4 | $262K | Hold |
3,300
| – | – | ﹤0.01% | 1637 |
|
|
2016
Q3 | $231K | Sell |
3,300
-50
| -1% | -$3.5K | ﹤0.01% | 1664 |
|
|
2016
Q2 | $132K | Buy |
3,350
+3,300
| +6,600% | +$130K | ﹤0.01% | 1957 |
|
|
2016
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 4414 |
|
|
2015
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 4159 |
|
|
2015
Q3 | – | Sell |
-405
| Closed | -$33K | – | 4759 |
|
|
2015
Q2 | $33K | Buy |
+405
| New | +$33K | ﹤0.01% | 2885 |
|